ArticleThe Lancet. Rheumatology2022
IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2.
Hamid Bassiri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Rheumatology2022
Hamid Bassiri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.